IJC Metabolic & Endocrine Influence of vitamin D levels on the treatment of premature ventricular complexes in patients with chronic kidney disease  Márcio Galindo Kiuchi, Gustavo Ramalho e Silva, Luis Marcelo Rodrigues Paz, Shaojie Chen, Neil Alexander Hoye, Gladyston Luiz Lima Souto  IJC Metabolic & Endocrine  Volume 14, Pages 53-58 (March 2017) DOI: 10.1016/j.ijcme.2017.01.002 Copyright © 2017 The Authors Terms and Conditions

Fig. 1 The flow chart of the study. IJC Metabolic & Endocrine 2017 14, 53-58DOI: (10.1016/j.ijcme.2017.01.002) Copyright © 2017 The Authors Terms and Conditions

Fig. 2 Changes in the minimum (Min), average (Ave) and maximum (Max) heart rates (HR) at baseline and at the 3rd month after β-onset in the 25(OH)D≤20ng/mL group (n=289), 25(OH)D 21–29ng/mL group (n=233), and 25(OH)D 30–100ng/mL group (n=302). *P<0.0001 to the comparison between baseline and 3months of follow-up for the same parameter into the same 25(OH)D group. Values are presented as mean±SD. IJC Metabolic & Endocrine 2017 14, 53-58DOI: (10.1016/j.ijcme.2017.01.002) Copyright © 2017 The Authors Terms and Conditions

Fig. 3 Decreases in the number of premature ventricular complexes (PVCs) at baseline and at the 3rd month after β-onset in the 25(OH)D≤20ng/mL group (n=289), 25(OH)D 21–29ng/mL group (n=233), and 25(OH)D 30–100ng/mL group (n=302). *P<0.0001 to the comparison between baseline and 3months of follow-up. Values are presented as mean±SD. IJC Metabolic & Endocrine 2017 14, 53-58DOI: (10.1016/j.ijcme.2017.01.002) Copyright © 2017 The Authors Terms and Conditions